Chronimed expands diagnostics through acquisition
This article was originally published in Clinica
Executive Summary
Chronimed has expanded its diagnostic product line through the acquisition of Dia-Screen, which produces blood and urine-based tests for lab and home testing. Dia-Screen is a leading contract developer of dry reagent chemistry technologies and Chronimed says the acquisition will result in a "natural fit" of both companies' products.